SPC339

Samsetning af Esafoxolaner, Eprinomectin og Praziquantel

  • Status:
    Veitt
  • Application date:
    22.6.2021
  • Application published:
    15.7.2021
  • Grant published:
    15.11.2022
  • Max expiry date:
    6.1.2036
  • Medicine name:
    NexGard Combo
  • Medicine for children:
    No

Timeline

Today
22.6.2021Application
15.7.2021Publication
15.11.2022Registration
6.1.2036Expires

Marketing license

  • IS authorization number:
    EU/2/20/267/001-004; EU/2/20/267/005-009
  • Date:
    25.1.2021
  • Foreign authorization number:
    EU/2/20/267
  • Date:
    6.1.2021

Owner

  • Name:
    Boehringer Ingelheim Animal Health USA Inc.
  • Address:
    3239 Satellite Boulevard Bldg. 500, Duluth, GA US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents